Also trades as: TCBPW (NASDAQ) · $vol 0M
TCBP NASDAQ
TC Biopharm (Holdings) Plc
1W: +63.3%
1M: -69.8%
3M: -93.8%
1Y: -99.8%
3Y: -100.0%
$0.50
Last traded 2025-04-17 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$11M
+31.0% ▲
Capital Expenditures
$110K
+54.2% ▲
4Y CAGR: -51.7%
Free Cash Flow
-$11M
+31.4% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$2M
-172.4% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$6M | -$5M | -$14M | -$1M | -$6M |
| Depreciation & Amort. | $904K | $1M | $1M | $959K | $633K |
| Stock-Based Comp. | $836K | $805K | $0 | $1M | $444K |
| Change in Working Capital | $258K | $2M | -$592K | -$800K | $2M |
| Other Non-Cash Items | -$3M | -$2M | $8M | -$15M | -$7M |
| Operating Cash Flow | -$7M | -$3M | -$6M | -$15M | -$11M |
| — Investing Activities — | |||||
| Capital Expenditures | -$2M | -$35K | -$20K | -$241K | -$110K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | -$170K | -$170K | -$123K | -$69K | -$98K |
| Investing Cash Flow | -$2M | -$205K | -$143K | -$310K | -$209K |
| — Financing Activities — | |||||
| Net Debt Issuance | $136K | -$415K | $6M | -$3M | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | -$53K | -$21K | $18M | $4M |
| Financing Cash Flow | $3M | $3M | $7M | $19M | $9M |
| Net Change in Cash | $956K | -$208K | $819K | $3M | -$2M |
| Cash End of Period | $956K | $748K | $2M | $5M | $2M |
| Free Cash Flow | -$9M | -$3M | -$6M | -$16M | -$11M |